<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7096384/results/search/disease/results.xml">
  <result pre="PengLianci1DuWenjuan2BalhuizenMelanie D.1HaagsmanHenk P.1de HaanCornelis A. M.2VeldhuizenEdwin J. A.1*[], 1Department of" exact="Infectious" post="Diseases &amp;amp; Immunology, Division of Molecular Host Defense, Faculty"/>
  <result pre="D.1HaagsmanHenk P.1de HaanCornelis A. M.2VeldhuizenEdwin J. A.1*[], 1Department of Infectious" exact="Diseases" post="&amp;amp; Immunology, Division of Molecular Host Defense, Faculty of"/>
  <result pre="Host Defense, Faculty of Veterinary Medicine, Utrecht UniversityUtrechtNetherlands[], 2Department of" exact="Infectious" post="Diseases &amp;amp; Immunology, Division Virology, Faculty of Veterinary Medicine,"/>
  <result pre="Defense, Faculty of Veterinary Medicine, Utrecht UniversityUtrechtNetherlands[], 2Department of Infectious" exact="Diseases" post="&amp;amp; Immunology, Division Virology, Faculty of Veterinary Medicine, Utrecht"/>
  <result pre="J. A. Veldhuizen, e.j.a.veldhuizen@uu.nl This article was submitted to Antimicrobials," exact="Resistance" post="and Chemotherapy, a section of the journal Frontiers in"/>
  <result pre="-2, -3, LL-37, PMAP-23, and K9CATH) with an inhibition of" exact="viral infection" post="up to 80% against three tested IAV strains (H1N1,"/>
  <result pre="-3, LL-37, PMAP-23, and K9CATH) with an inhibition of viral" exact="infection" post="up to 80% against three tested IAV strains (H1N1,"/>
  <result pre="to or after their inoculation with virus did not reduce" exact="viral infection" post="indicating that direct interaction of virus with the peptide"/>
  <result pre="or after their inoculation with virus did not reduce viral" exact="infection" post="indicating that direct interaction of virus with the peptide"/>
  <result pre="of virus and peptide also indicated that CATH-B1 bound to" exact="viral" post="particles. In addition, using electron microscopy, no morphological change"/>
  <result pre="upon incubation with CATH-B1 but large aggregates of CATH-B1 and" exact="viral" post="particles were observed, indicating that aggregation might be the"/>
  <result pre="has good antiviral activity against IAV by binding to the" exact="viral" post="particle and thereby blocking viral entry. host defense peptides"/>
  <result pre="IAV by binding to the viral particle and thereby blocking" exact="viral" post="entry. host defense peptides cathelicidins influenza innate immunity infection"/>
  <result pre="blocking viral entry. host defense peptides cathelicidins influenza innate immunity" exact="infection" post="fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction Cathelicidins are"/>
  <result pre="infection fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction Cathelicidins are" exact="short" post="cationic peptides with an important role in the innate"/>
  <result pre="response against infections. They are mainly expressed by leukocytes and" exact="epithelial" post="cells at infection sites in the host. Cathelicidins have"/>
  <result pre="They are mainly expressed by leukocytes and epithelial cells at" exact="infection" post="sites in the host. Cathelicidins have been found in"/>
  <result pre="virus (IAV) is an important pathogen of human and animals." exact="Infection" post="with IAV causes acute respiratory diseases leading to morbidity"/>
  <result pre="important pathogen of human and animals. Infection with IAV causes" exact="acute" post="respiratory diseases leading to morbidity and mortality in human"/>
  <result pre="pathogen of human and animals. Infection with IAV causes acute" exact="respiratory" post="diseases leading to morbidity and mortality in human and"/>
  <result pre="and treat IAV infections. The efficacy of vaccination is, however," exact="limited" post="in part due to antigenic variation, while the use"/>
  <result pre="to antigenic variation, while the use of anti-IAV drugs is" exact="limited" post="by the development of resistance. Therefore, novel preventive and"/>
  <result pre="of resistance. Therefore, novel preventive and therapeutic options against IAV" exact="infection" post="are needed. In this study, we investigated the antiviral"/>
  <result pre="were determined for MDCK-II cells by calculating 50% tissue culture" exact="infectious" post="dose per ml (TCID50/mL) as described before (Reed and"/>
  <result pre="per ml (TCID50/mL) as described before (Reed and Muench, 1938)." exact="Viral Infection" post="MDCK-II and HD11 cells, seeded in 96 well plates"/>
  <result pre="ml (TCID50/mL) as described before (Reed and Muench, 1938). Viral" exact="Infection" post="MDCK-II and HD11 cells, seeded in 96 well plates"/>
  <result pre="to confluency, were infected with virus at a multiplicity of" exact="infection" post="(MOI) of 0.1 in the presence or absence of"/>
  <result pre="multiplicity of infection (MOI) of 0.1 in the presence or" exact="absence of" post="cathelicidins for 1 h at 37°C. In pre-incubation studies"/>
  <result pre="order of peptide and virus addition reversed. All the initial" exact="infection" post="and cathelicidin incubation steps were performed in the absence"/>
  <result pre="initial infection and cathelicidin incubation steps were performed in the" exact="absence of" post="serum. After these incubations, unbound virus or unbound peptide"/>
  <result pre="−20°C for 5 min, after which cells were stained with" exact="primary" post="mouse monoclonal antibody HB65 (1:1000) specific for the nucleoprotein"/>
  <result pre="per well were taken using an EVOS FL microscope (Thermo" exact="Fisher" post="Scientific) and the infected cells were counted. The number"/>
  <result pre="Influenza A virus (H3N1) was incubated in the presence or" exact="absence of" post="CATH-B1 for 1 h at 37°C and 10 μl"/>
  <result pre="(2.5 ug/mL) was coated on Maxisorp Nunc 96-well plates (Thermo" exact="Fisher" post="Scientific). Plates were incubated with IAV PR8 (1.78 ×"/>
  <result pre="IAV PR8 (1.78 × 108 PFU/mL) in the presence or" exact="absence of" post="5 μM CATH-B1 (in 50 mM Tris–HCl with 4"/>
  <result pre="lectin (Vector laboratories) (1.5 μg/ml) in combination with streptavidin-HRP (Thermo" exact="Fisher" post="Scientific) (1:1000). After washing, TMB was added and plates"/>
  <result pre="infected with virus for 1 h at the multiplicity of" exact="infection" post="(MOI) of 1 in the presence or absence of"/>
  <result pre="multiplicity of infection (MOI) of 1 in the presence or" exact="absence of" post="CATH-B1 as described above. After 8 or 24 h"/>
  <result pre="CATH-B1 as described above. After 8 or 24 h incubation," exact="total" post="RNA was extracted by Trizol (Ambion, Carlsbad, CA, United"/>
  <result pre="MDCK cells were inoculated with IAVs in the presence or" exact="absence of" post="5 μM cathelicidins for 1 h. After 1 h,"/>
  <result pre="were incubated for another 7 h. At 8 hours post" exact="infection" post="(hpi), the number of infected cells was quantified by"/>
  <result pre="for some of them depended to some extent on the" exact="viral" post="strain and the cell line used. PMAP-23 and K9"/>
  <result pre="Interestingly, LL-37 only showed activity against H3N1 and to a" exact="lower" post="extent H1N1 but not against H5N1, while the chicken"/>
  <result pre="infectivity of 40–70%. However, regardless of the cell line or" exact="viral" post="strain used, CATH-B1 clearly displayed the strongest antiviral activity,"/>
  <result pre="strain used, CATH-B1 clearly displayed the strongest antiviral activity, inhibiting" exact="infection" post="up to 80–90%. FIGURE 1 The antiviral effect of"/>
  <result pre="strains before addition to either HD11 or MDCK cells. H1N1/PR8" exact="infection" post="in the presence of cathelicidins of HD11 (A) or"/>
  <result pre="of cathelicidins of HD11 (A) or MDCK (B) cells. H3N1" exact="infection" post="in the presence of cathelicidins of HD11 (C) or"/>
  <result pre="of cathelicidins of HD11 (C) or MDCK (D) cells. H5N1" exact="infection" post="in the presence of cathelicidins of HD11 (E) and"/>
  <result pre="presence of cathelicidins of HD11 (E) and MDCK (F) cells." exact="Viral infection" post="was determined by immunofluorescent detection of IAV nuclear protein."/>
  <result pre="of cathelicidins of HD11 (E) and MDCK (F) cells. Viral" exact="infection" post="was determined by immunofluorescent detection of IAV nuclear protein."/>
  <result pre="well were taken and the infected cells were counted. The" exact="infection" post="rate in the presence of cathelicidins was normalized against"/>
  <result pre="infectivity of CATH-B1 was dose-dependent (Figure 2), with an almost" exact="complete" post="inhibition of viral infectivity of the H1N1 and H3N1"/>
  <result pre="was dose-dependent (Figure 2), with an almost complete inhibition of" exact="viral" post="infectivity of the H1N1 and H3N1 strains, while inhibition"/>
  <result pre="of CATH-B1 against IAV strains (H1N1/PR8, H3N1 and H5N1). (A)" exact="Viral infection" post="in the presence of CATH-B1 in HD11 cells, (B)"/>
  <result pre="CATH-B1 against IAV strains (H1N1/PR8, H3N1 and H5N1). (A) Viral" exact="infection" post="in the presence of CATH-B1 in HD11 cells, (B)"/>
  <result pre="infection in the presence of CATH-B1 in HD11 cells, (B)" exact="Viral infection" post="in the presence of CATH-B1 in MDCK cells. Viral"/>
  <result pre="in the presence of CATH-B1 in HD11 cells, (B) Viral" exact="infection" post="in the presence of CATH-B1 in MDCK cells. Viral"/>
  <result pre="Viral infection in the presence of CATH-B1 in MDCK cells." exact="Viral infection" post="was determined by immunofluorescent detection of IAV nuclear protein."/>
  <result pre="infection in the presence of CATH-B1 in MDCK cells. Viral" exact="infection" post="was determined by immunofluorescent detection of IAV nuclear protein."/>
  <result pre="well were taken and the infected cells were counted. The" exact="infection" post="rate in the presence of cathelicidins was normalized against"/>
  <result pre="HD11 or MDCK cells or by an inhibitory effect on" exact="viral" post="replication after the viruses entered the cells, but that"/>
  <result pre="the viruses entered the cells, but that CATH-B1 likely blocked" exact="viral" post="entry to the cells by direct interaction with the"/>
  <result pre="Cytokines in HD11 Cells Activation of macrophages is important for" exact="viral" post="clearance during IAV infection, but an excessive inflammatory response"/>
  <result pre="extent the presence of CATH-B1 affected these responses induced by" exact="infection" post="of cells with IAV. To this end, virus-induced gene"/>
  <result pre="HD11 macrophages was determined by qPCR in the presence or" exact="absence of" post="CATH-B1. Virus infection resulted in induced gene expression of"/>
  <result pre="by qPCR in the presence or absence of CATH-B1. Virus" exact="infection" post="resulted in induced gene expression of IFN-β, IL-1β, IL-6,"/>
  <result pre="and LL-37 also showed similar effects on gene expression upon" exact="virus infection," post="but the inhibition was not as pronounced as observed"/>
  <result pre="for CATH-B1, correlating with the effect of the peptides on" exact="virus infection" post="shown in Figure 1. The effect of CATH-B1 on"/>
  <result pre="CATH-B1, correlating with the effect of the peptides on virus" exact="infection" post="shown in Figure 1. The effect of CATH-B1 on"/>
  <result pre="cells were incubated with CATH-B1 prior to, or immediately after" exact="virus infection" post="(Figure 4B), indicating that the reduction of the response"/>
  <result pre="were incubated with CATH-B1 prior to, or immediately after virus" exact="infection" post="(Figure 4B), indicating that the reduction of the response"/>
  <result pre="in HD11 cells at 24 hpi in the presence or" exact="absence of" post="peptides. (B) Cytokine expression in HD11 cells for pre-"/>
  <result pre="of CATH-B1 With IAV The inhibitory effect of CATH-B1 on" exact="virus infection" post="and induction of cytokine responses is only observed when"/>
  <result pre="CATH-B1 With IAV The inhibitory effect of CATH-B1 on virus" exact="infection" post="and induction of cytokine responses is only observed when"/>
  <result pre="are exposed to the peptides prior to, or immediately after" exact="virus infection." post="This suggests that a direct interaction of the peptide"/>
  <result pre="of CATH-B1 to virus is almost instantaneous because in the" exact="absence of" post="the 30 min incubation time upon mixing of virus"/>
  <result pre="(Virus containing) supernatant was then used to infect HD11 cells." exact="Viral infection" post="was determined by immunofluorescent detection of IAV nuclear protein."/>
  <result pre="containing) supernatant was then used to infect HD11 cells. Viral" exact="infection" post="was determined by immunofluorescent detection of IAV nuclear protein."/>
  <result pre="well were taken and the infected cells were counted. The" exact="infection" post="rate in the presence of CATH-B1 was normalized against"/>
  <result pre="such as human neutrophil defensins, have been shown to induce" exact="viral" post="aggregation, which might contribute to their antiviral activity (Hartshorn"/>
  <result pre="such as LL-37 have been found to directly disrupt the" exact="viral" post="membrane (Tripathi et al., 2013). To study the effect"/>
  <result pre="et al., 2013). To study the effect of CATH-B1 on" exact="viral" post="morphology, H3N1 was used in this study as an"/>
  <result pre="in Figure 6, there is no clear alteration of the" exact="viral" post="structure upon incubation with 20 μM CATH-B1 (Figure 6B),"/>
  <result pre="LL-37 (Figure 6D), However, large aggregates were observed that contained" exact="viral" post="particles and electron dense material at high concentration (20"/>
  <result pre="mechanism of CATH-B1. FIGURE 6 The effect of CATH-B1 on" exact="viral" post="morphology. Representative electron microscopic images of (A) H3N1 IAV"/>
  <result pre="Shown are representative images at 60,000x magnification (A–D) to visualize" exact="morphology" post="of individual virus particles, or 16,500 × magnification (E–J)"/>
  <result pre="particles, or 16,500 × magnification (E–J) to visualize aggregation of" exact="viral" post="particles. Large peptides aggregates (black arrows) containing viruses and"/>
  <result pre="are important functional proteins on the surface of IAVs. During" exact="viral infection," post="the function of HA is binding to sialic acid"/>
  <result pre="H1N1/PR8 was directly measured using MUNANA substrate in presence or" exact="absence of" post="CATH-B1. (B) Desialylated N-glycans of fetuin were detected using"/>
  <result pre="HRP-conjugated ECA lectins, after incubation with H1N1/PR8 in presence or" exact="absence of" post="CATH-B1. Data are represented as mean ± SEM of"/>
  <result pre="has been found to have antiviral activity against IAV, adenovirus," exact="respiratory" post="syncytial virus and HIV (Bergman et al., 2007; Barlow"/>
  <result pre="of chicken cathelicidins, since IAV is an important pathogen causing" exact="disease" post="in chicken and also in humans. Four chicken cathelicidins"/>
  <result pre="fragment of LL-37 played a critical role in inhibiting the" exact="infection" post="IAV (Tripathi et al., 2015). Future mutational studies on"/>
  <result pre="the bursa of Fabricius. The peptide is expressed by secretory" exact="epithelial" post="cells but is located after secretion surrounding bursal M-cells"/>
  <result pre="Sekelova et al., 2017) where the peptide is released upon" exact="infection" post="(Van Dijk et al., 2009). In order to determine"/>
  <result pre="order to determine if CATH-B1 is important in vivo against" exact="viral" post="infections, more detailed studies on its expression and localization"/>
  <result pre="CATH-B1 is indeed only present in the bursa, only a" exact="limited" post="antiviral role against for example infectious bursal disease virus"/>
  <result pre="the bursa, only a limited antiviral role against for example" exact="infectious" post="bursal disease virus can be envisioned, but not really"/>
  <result pre="only a limited antiviral role against for example infectious bursal" exact="disease" post="virus can be envisioned, but not really against IAV"/>
  <result pre="not restricted to the bursa of Fabricius. Although at much" exact="lower" post="levels than found in the bursa, CATH-B1 mRNA was"/>
  <result pre="in several tissues, including spleen and multiple segments of the" exact="respiratory" post="and gastrointestinal tract of chicken (Achanta et al., 2012;"/>
  <result pre="gene expression was also observed in chicken HD11 macrophages and" exact="primary" post="monocytes (Sunkara, 2011). Finally, some studies have described induced"/>
  <result pre="vitro, indicating that higher CATH-B1 levels in multiple tissues upon" exact="viral infection" post="could be obtained. TABLE 2 Characteristics of peptides used"/>
  <result pre="indicating that higher CATH-B1 levels in multiple tissues upon viral" exact="infection" post="could be obtained. TABLE 2 Characteristics of peptides used"/>
  <result pre="found to directly interact with the IAV virion thereby limiting" exact="viral" post="replication and virus-induced inflammation in vivo (Barlow et al.,"/>
  <result pre="LL-37 was described to directly induce disruption of the IAV" exact="viral" post="membrane (Tripathi et al., 2013), although we did not"/>
  <result pre="in our current study, possibly related to differences in the" exact="viral" post="strains used. Human neutrophil peptides (HNPs) have been shown"/>
  <result pre="used. Human neutrophil peptides (HNPs) have been shown to induce" exact="viral" post="aggregation and inhibit infectivity mainly through direct interactions with"/>
  <result pre="against IAV and HIV-1 but mainly through immunomodulatory effects during" exact="viral infection" post="(Wang et al., 2004; Ryan et al., 2011). The"/>
  <result pre="IAV and HIV-1 but mainly through immunomodulatory effects during viral" exact="infection" post="(Wang et al., 2004; Ryan et al., 2011). The"/>
  <result pre="al., 2011). The current study showed that CATH-B1 binds to" exact="viral" post="particles but this was not accompanied by any obvious"/>
  <result pre="this was not accompanied by any obvious disruption of the" exact="viral" post="membrane. Instead, peptide-virus aggregates were observed using electron microscopy,"/>
  <result pre="CATH-B1 might exert this mechanism of aggregating pathogens to block" exact="infection" post="for viral invasion. The viral membrane of IAV is"/>
  <result pre="exert this mechanism of aggregating pathogens to block infection for" exact="viral" post="invasion. The viral membrane of IAV is characterized by"/>
  <result pre="of aggregating pathogens to block infection for viral invasion. The" exact="viral" post="membrane of IAV is characterized by the two key"/>
  <result pre="and neuraminidase (NA), both of which are important for IAV" exact="infection" post="and could potentially be affected by binding of CATH-B1"/>
  <result pre="could potentially be affected by binding of CATH-B1 to the" exact="viral" post="surface. HA functions as a receptor binding and fusion"/>
  <result pre="inhibited virus-receptor binding activity, in agreement with CATH-B1 only affecting" exact="virus infection" post="when present during virus inoculation. Presumably the inhibiting effect"/>
  <result pre="virus-receptor binding activity, in agreement with CATH-B1 only affecting virus" exact="infection" post="when present during virus inoculation. Presumably the inhibiting effect"/>
  <result pre="antiviral mechanisms, such as the interaction of CATH-B1 with the" exact="viral" post="membrane should be explored further. This antiviral mechanism of"/>
  <result pre="likely by interfering with HA-mediated virus-receptor binding and thereby blocking" exact="viral" post="entry. This new activity is important to understand the"/>
  <result pre="The authors declare that the research was conducted in the" exact="absence of" post="any commercial or financial relationships that could be construed"/>
  <result pre="S1 The effect of pre-incubation or post-incubation of cathelicidins on" exact="viral" post="replication of H1N1/PR8 strain. PR8 infection in HD11 cells"/>
  <result pre="post-incubation of cathelicidins on viral replication of H1N1/PR8 strain. PR8" exact="infection" post="in HD11 cells (A) or MDCK cells (B) for"/>
  <result pre="(A) or MDCK cells (B) for pre-incubation with cathelicidins. PR8" exact="infection" post="in HD11 cells (C) or MDCK cells (D) for"/>
  <result pre="cells (C) or MDCK cells (D) for post-incubation with cathelicidins." exact="Viral infection" post="was determined by immunofluorescent detection of IAV nuclear protein."/>
  <result pre="(C) or MDCK cells (D) for post-incubation with cathelicidins. Viral" exact="infection" post="was determined by immunofluorescent detection of IAV nuclear protein."/>
  <result pre="well were taken and the infected cells were counted. The" exact="infection" post="rate in the presence of cathelicidins was normalized against"/>
  <result pre="in HD11 cells at 8 hpi in the presence or" exact="absence of" post="peptides. Relative gene expression levels were normalized against the"/>
  <result pre="(Virus containing) supernatant was then used to infect MDCK cells." exact="Viral infection" post="was determined by immunofluorescent detection of IAV nuclear protein."/>
  <result pre="containing) supernatant was then used to infect MDCK cells. Viral" exact="infection" post="was determined by immunofluorescent detection of IAV nuclear protein."/>
  <result pre="well were taken and the infected cells were counted. The" exact="infection" post="rate in the presence of cathelicidins was normalized against"/>
  <result pre="al. (2011). Antiviral activity and increased host defense against influenza" exact="infection" post="elicited by the human cathelicidin LL-37.PLoS One6:e25333. 10.1371/journal.pone.002533322031815 BergmanP.Walter-JallowL.BrolidenK.AgerberthB.SoderlundJ."/>
  <result pre="past and present.Annu. Rev. Med.51407–421. 10.1146/annurev.med.51.1.40710774473 CuperusT.CoorensM.van DijkA.HaagsmanH. P. (2013)." exact="Avian" post="host defense peptides.Dev. Comp. Immunol.41352–369. 10.1016/j.dci.2013.04.01923644014 CuperusT.van DijkA.MatthijsM. G.VeldhuizenE."/>
  <result pre="J.FitchP. M.BöttcherB.ColegraveN.et al. (2016). Cathelicidins have direct antiviral activity against" exact="respiratory" post="syncytial virus in vitro and protective function in vivo"/>
  <result pre="HögnerK.WolffT.PleschkaS.PlogS.GruberA. D.KalinkeU.et al. (2013). Macrophage-expressed IFN-β contributes to apoptotic alveolar" exact="epithelial" post="cell injury in severe influenza virus pneumonia.PLoS Pathog.9:e1003188. 10.1371/journal.ppat.100318827304804"/>
  <result pre="Intern. Med.160684–694. 10.7326/m13-207124842415 KimH. M.LeeY.-W.LeeK.-J.KimH. S.ChoS. W.Van RooijenN.et al. (2008)." exact="Alveolar" post="macrophages are indispensable for controlling influenza viruses in lungs"/>
  <result pre="al. (2017). Genetic versus antigenic differences among highly pathogenic H5N1" exact="avian influenza" post="A viruses: consequences for vaccine strain selection.Virology50383–93. 10.1016/j.virol.2017.01.01228135661 ReedL."/>
  <result pre="human β-defensin-1 (hBD-1) in plasmacytoid dendritic cells (PDC), monocytes, and" exact="epithelial" post="cells by influenza virus, Herpes simplex virus, and Sendai"/>
  <result pre="protein expression in chicken macrophages and heterophils in vivo following" exact="infection" post="with Salmonella Enteritidis.Vet. Res.48:35. 10.1186/s13567-017-0439-028623956 SunkaraL. T. (2011). Enhancing"/>
  <result pre="Res.48:35. 10.1186/s13567-017-0439-028623956 SunkaraL. T. (2011). Enhancing Chicken Innate Immunity and" exact="Disease" post="Resistance by Boosting Host Defense Peptide Synthesis.Stillwater, OK: Oklahoma"/>
  <result pre="10.1186/s13567-017-0439-028623956 SunkaraL. T. (2011). Enhancing Chicken Innate Immunity and Disease" exact="Resistance" post="by Boosting Host Defense Peptide Synthesis.Stillwater, OK: Oklahoma State"/>
  <result pre="P. (2009). Chicken heterophils are recruited to the site of" exact="Salmonella infection" post="and release antibacterial mature Cathelicidin-2 upon stimulation with LPS.Mol."/>
  <result pre="(2009). Chicken heterophils are recruited to the site of Salmonella" exact="infection" post="and release antibacterial mature Cathelicidin-2 upon stimulation with LPS.Mol."/>
  <result pre="L.ColeA. M.HongT.WaringA. J.et al. (2004). Activity of α-and θ-defensins against" exact="primary" post="isolates of HIV-1.J. Immunol.173515–520. 10.4049/jimmunol.173.1.51515210812 WebbyR. J.WebsterR. G. (2003)."/>
 </snippets>
</snippetsTree>
